Endo Health Solutions Names New CEO

Biotech firm Endo Health Solutions (NASDAQ: ENDP  ) announced in a press release recently that it has named former Valeant Pharmaceuticals (NYSE: VRX  ) President Rajiv De Silva as the company's new CEO, replacing retiring CEO David Holveck.

De Silva has served with Valeant since 2009, also acting as the company's chief operating officer of its specialty pharmaceuticals branch. He expressed his excitement in the statement, pledging to commit to top-line growth, improve cost management, and create shareholder value.

Endo Chairman of the Board Roger H. Kimmel expressed his own thoughts in the statement, saying, "[De Silva's] track record in generating growth and profitability, managing complex integrations, and delivering for shareholders will serve us well."


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2283357, ~/Articles/ArticleHandler.aspx, 10/23/2014 6:04:30 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement